CMS Seeks Comments on Small Biotech Exemption in Drug Pricing Regulation

CMS has posted an Information Collection Request (ICR) on the Small Biotech Exception to the Medicare drug pricing negotiation program established under the “Inflation Reduction Act” just passed by the last Congress in late 2022. Comments must be received by March 27.

Leave a Comment